Citigroup’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.8K Sell
22,760
-21,164
-48% -$79.8K ﹤0.01% 3760
2025
Q1
$199K Sell
43,924
-4,035
-8% -$18.3K ﹤0.01% 3445
2024
Q4
$339K Buy
47,959
+3,797
+9% +$26.8K ﹤0.01% 3262
2024
Q3
$359K Buy
44,162
+27,401
+163% +$223K ﹤0.01% 3195
2024
Q2
$107K Buy
16,761
+5,500
+49% +$35.1K ﹤0.01% 3453
2024
Q1
$84.8K Sell
11,261
-27,552
-71% -$207K ﹤0.01% 3628
2023
Q4
$359K Buy
38,813
+37,748
+3,544% +$350K ﹤0.01% 2896
2023
Q3
$10.8K Sell
1,065
-33,477
-97% -$339K ﹤0.01% 3814
2023
Q2
$432K Buy
34,542
+33,019
+2,168% +$413K ﹤0.01% 2831
2023
Q1
$17.8K Sell
1,523
-139
-8% -$1.62K ﹤0.01% 3901
2022
Q4
$17.7K Sell
1,662
-1,200
-42% -$12.8K ﹤0.01% 3947
2022
Q3
$28K Sell
2,862
-4,037
-59% -$39.5K ﹤0.01% 3900
2022
Q2
$100K Buy
6,899
+2,828
+69% +$41K ﹤0.01% 3553
2022
Q1
$107K Sell
4,071
-11,027
-73% -$290K ﹤0.01% 3695
2021
Q4
$598K Buy
15,098
+7,652
+103% +$303K ﹤0.01% 2935
2021
Q3
$372K Sell
7,446
-10,256
-58% -$512K ﹤0.01% 3087
2021
Q2
$983K Buy
17,702
+13,715
+344% +$762K ﹤0.01% 2629
2021
Q1
$186K Sell
3,987
-2,932
-42% -$137K ﹤0.01% 3397
2020
Q4
$301K Buy
6,919
+5,118
+284% +$223K ﹤0.01% 2973
2020
Q3
$66K Sell
1,801
-5,209
-74% -$191K ﹤0.01% 3341
2020
Q2
$204K Buy
7,010
+1,113
+19% +$32.4K ﹤0.01% 3067
2020
Q1
$154K Buy
5,897
+3,882
+193% +$101K ﹤0.01% 3015
2019
Q4
$70K Buy
2,015
+1,641
+439% +$57K ﹤0.01% 3756
2019
Q3
$11K Buy
+374
New +$11K ﹤0.01% 4526